Sign In
Buy XBI
$129.83
+2.07 (+1.62%)
At Close: Jun 03, 2026
Biotech ETFs Are Making a Comeback
09:16pm, Tuesday, 05'th Jul 2022
Biotechnology stocks and sector-related exchange traded funds have been gaining momentum as investors return to this downtrodden segment of the market. Over the past month, the Virtus LifeSci Biotech
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
10:52am, Tuesday, 05'th Jul 2022
Sector ETF report for XBI
Use This 1 Genius Trick for Finding Dirt Cheap Biotech Stocks in the Bear Market
10:23am, Saturday, 02'nd Jul 2022
This metric will show you which companies are being valued at potentially unreasonably low levels.
Joseph Fahmy: Biotech is likely to outperform in the second half of the year
08:12am, Friday, 01'st Jul 2022
Joseph Fahmy, Managing Director at Zor Capital, joins Worldwide Exchange to discuss why he's bullish on biotech stocks, including the XBI ETF.
ETFs Winners of S&P 500's Second Best Week in 2022
04:58pm, Monday, 27'th Jun 2022
The S&P 500 advanced more than 3% on Friday, logging back-to-back days of gains and marking its first weekly advance since late May.
Final Trades: CHPT, BMY, WMT & XBI
08:13pm, Friday, 24'th Jun 2022
The final trades of the week. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Steve Grasso, Guy Adami and Pete Najarian.
3 Beaten-Down ETFs to Buy Before They Rebound
02:25pm, Thursday, 23'rd Jun 2022
The charts are improving for these fallen angels, and that makes them all top ETFs to buy for the back half of the year. The post 3 Beaten-Down ETFs to Buy Before They Rebound appeared first on Invest
Should You Sell Biotech Stocks If There's a Recession?
10:37am, Thursday, 23'rd Jun 2022
It's probably better to think about whether to buy more shares.
XLV, XBI: Why We're Bullish On Healthcare (Generally) And Biotech (Specifically)
03:41am, Friday, 17'th Jun 2022
In spite of half of our FMP's four building blocks trading in distress-mode, the portfolio/investment strategy is working just fine. Although stocks are no longer expensive, the economy is looking so
Stocks Fall Into Bear Market
05:27pm, Monday, 13'th Jun 2022
The S&P 500 fell more than 20% below its all-time high on Monday.
XBI Or IBB: How To Play The Oversold Biotech Most Efficiently
08:51am, Thursday, 09'th Jun 2022
Biotechnology sector stocks seem to be in the oversold zone, as indicated by their momentum and valuations. I compared XBI (small-cap biotech ETF) and IBB (all-cap biotech ETF) to select the most prom
Biotech ETFs Strengthen as Bristol Myers Squibb Buys Turning Point
06:51pm, Friday, 03'rd Jun 2022
Biotechnology sector-related exchange traded funds were in a bright spot on Friday after Bristol Myers Squibb Co. (NYSE: BMY) said it will acquire drug developers Turning Point Therapeutics (NasdaqGS:
A biotech self-correction is in store, says Oppenheimer's Jared Holz
07:02pm, Tuesday, 31'st May 2022
Jared Holz, Oppenheimer healthcare equity strategist, on biotech stocks to watch. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Karen Finerman, Steve Grasso and Bonawyn Eison.
📈 Two Charts Show That Biotech Is in for a Stock Rebound
10:50am, Monday, 23'rd May 2022
COVID lows, post-2008 uptrend support and bullishly oversold conditions are all converging now. A biotech stock rebound could be on its way.
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
07:32am, Wednesday, 18'th May 2022
Smart Beta ETF report for XBI
